Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients.

Autor: Nilsson L; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden; Department of Medical Physics and Engineering, Växjö Central Hospital and Department of Research and Development, Region Kronoberg, Växjö, Sweden., Khazaei S; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Tryggvadottir H; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden., Björner S; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Bressan A; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Jirström K; Department of Clinical Sciences, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden., Adrian G; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden., Falck AK; Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden., Borgquist S; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden; Department of Oncology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Isaksson K; Department of Clinical Sciences, Division of Surgery, Lund University, Lund, Sweden; Department of Surgery, Kristianstad Hospital, Kristianstad, Sweden., Jernström H; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden. Electronic address: helena.jernstrom@med.lu.se.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2024 Apr; Vol. 24 (3), pp. e152-e166.e9. Date of Electronic Publication: 2023 Dec 21.

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.

Autor: Forsare C; Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden. carina.forsare@med.lu.se., Bak M; Department of Pathology, Odense University Hospital, DK-5000, Odense, Denmark., Falck AK; Department of Surgery, Helsingborg Hospital, SE-281 85, Helsingborg, Sweden., Grabau D; Department of Pathology, Lund University, Skåne University Hospital, SE-221 85, Lund, Sweden., Killander F; Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.; Department of Haematology, Oncology and Radiation physics, Skane University Hospital, SE-221 85, Lund, Sweden., Malmström P; Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.; Department of Haematology, Oncology and Radiation physics, Skane University Hospital, SE-221 85, Lund, Sweden., Rydén L; Faculty of Medicine, Department of Clinical Sciences Lund, Division of Surgery, Skåne University Hospital, Lund University, SE-221 85, Lund, Sweden.; Department of Surgery and Gastroenterology, Skåne University Hospital, SE-205 02, Malmö, Sweden., Stål O; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, SE-581 85, Linköping, Sweden., Sundqvist M; Department of Surgery, County Hospital, SE-391 85, Kalmar, Sweden., Bendahl PO; Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden., Fernö M; Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Medicon Village Building 404, Scheelevägen 2, SE-223 81, Lund, Sweden.

Publikováno v: BMC cancer [BMC Cancer] 2018 Dec 07; Vol. 18 (1), pp. 1226. Date of Electronic Publication: 2018 Dec 07.

Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.

Autor: Ehinger A; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden.; b Department of Pathology and Cytology , Blekinge County Hospital , Karlskrona , Sweden., Malmström P; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden.; c Department of Oncology , Skåne University Hospital , Lund , Sweden., Bendahl PO; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden., Elston CW; d Department of Histopathology , Nottingham University Hospitals NHS Trust , Nottingham , UK., Falck AK; e Department of Surgery , Helsingborg Hospital , Helsingborg , Sweden., Forsare C; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden., Grabau D; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden.; f Department of Pathology , Skåne University Hospital , Lund , Sweden., Rydén L; g Division of Surgery, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden.; h Department of Surgery , Skåne University Hospital , Lund , Sweden., Stål O; i Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences , Linköping University , Linköping , Sweden., Fernö M; a Division of Oncology and Pathology, Department of Clinical Sciences , Lund Cancer Center at Medicon Village, Lund University , Lund , Sweden.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2017 Jan; Vol. 56 (1), pp. 68-74. Date of Electronic Publication: 2016 Oct 20.

The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.

Autor: Jansson S; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Bendahl PO; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Grabau DA; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Falck AK; Department of Surgery, Hospital of Helsingborg, Helsingborg, Sweden., Fernö M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Aaltonen K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Rydén L; Division of Surgery, Department of Clinical Sciences Lund, Skåne University Hospital, Lund, Sweden.

Publikováno v: PloS one [PLoS One] 2014 Jul 15; Vol. 9 (7), pp. e102176. Date of Electronic Publication: 2014 Jul 15 (Print Publication: 2014).

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.

Autor: Falck AK; Department of Surgery, Clinical Sciences, Lund University, Lund SE-22185, Sweden. Lisa.Ryden@med.lu.se., Fernö M, Bendahl PO, Rydén L

Publikováno v: BMC cancer [BMC Cancer] 2013 Nov 25; Vol. 13, pp. 558. Date of Electronic Publication: 2013 Nov 25.